Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center

Purpose/Objective: Around 30% of patients with non-small cell lung cancers (NSCLC) are diagnosed with stage III disease at presentation, of which about 50% are treated with definitive chemoradiation (CRT). Around 65–80% of patients will eventually develop intracranial metastases (IM), though associa...

Full description

Bibliographic Details
Main Authors: Stephane Thibodeau, Mahbuba Meem, Wilma Hopman, Simran Sandhu, Osbert Zalay, Andrea S. Fung, Adi Kartolo, Geneviève C. Digby, Shahad Al-Ghamdi, Andrew Robinson, Allison Ashworth, Timothy Owen, Aamer Mahmud, Kit Tam, Timothy Olding, Fabio Ynoe de Moraes
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Chemoradiation
Intracranial metastasis
Treatment delay
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294223000692

Internet

http://www.sciencedirect.com/science/article/pii/S2468294223000692

Similar Items